Regulatory Challenges, Reimbursement, and Risk-Benefit Assessment

被引：14
|
作者：
Breckenridge, A. [1 ]
机构：
[1] Med & Healthcare Prod Regulatory Agcy, London, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 02期
关键词：
D O I：
10.1038/clpt.2010.76
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [31] Carbapenems in serious infections - A risk-benefit assessment
    Norrby, SR
    DRUG SAFETY, 2000, 22 (03) : 191 - 194
  • [32] Risk-benefit assessment of nimesulide urgently needed
    Reactions Weekly, 2003, 934 (1) : 3 - 3
  • [33] RISK-BENEFIT ASSESSMENT OF ANESTHETIC AGENTS IN THE PUERPERIUM
    KANTO, J
    DRUG SAFETY, 1991, 6 (04) : 285 - 301
  • [34] A TIERED APPROACH FOR RISK-BENEFIT ASSESSMENT OF FOODS
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 661 - 661
  • [35] RISK-BENEFIT PROBLEMS IN FOOD SAFETY ASSESSMENT
    FRANCIS, FJ
    JOURNAL OF THE CANADIAN DIETETIC ASSOCIATION-REVUE DE L ASSOCIATION CANADIENNE DES DIETETISTES, 1979, 40 (04): : 274 - 279
  • [36] RISK-BENEFIT
    MCCLUNG, N
    JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1978, 8 (01): : 107 - 108
  • [37] A risk-benefit assessment of mirtazapine in the treatment of depression
    Kasper, S
    PraschakRieder, N
    Tauscher, J
    Wolf, R
    DRUG SAFETY, 1997, 17 (04) : 251 - 264
  • [38] RISK-BENEFIT ASSESSMENT OF ANTICOAGULANT-THERAPY
    HARRINGTON, R
    ANSELL, J
    DRUG SAFETY, 1991, 6 (01) : 54 - 69
  • [39] A Risk-Benefit Assessment of Therapies for Premature Labour
    Kenneth Higby
    Cheryl R. Suiter
    Drug Safety, 1999, 21 : 35 - 56
  • [40] A Tiered Approach for Risk-Benefit Assessment of Foods
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    RISK ANALYSIS, 2010, 30 (05) : 808 - 816
12345